Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.38B |
| 2 |
Blackrock
BLK
|
+$2.31B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.87B |
| 4 |
Microsoft
MSFT
|
+$1.6B |
| 5 |
Diamondback Energy
FANG
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.19B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$3.04B |
| 3 |
JPMorgan Chase
JPM
|
+$1.99B |
| 4 |
Morgan Stanley
MS
|
+$1.94B |
| 5 |
Caterpillar
CAT
|
+$1.9B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.13% |
| 2 | Healthcare | 17.38% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.42% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Prime Medicine
PRME
$559M
| $968K | ﹤0.01% |
278,120
+29,893
| +12% | +$114K |
|
1627
Aclaris Therapeutics
ACRS
$869M
| $964K | ﹤0.01% |
257,156
-7,203
| -3% | -$24.3K |
|
1628
Enanta Pharmaceuticals
ENTA
$400M
| $947K | ﹤0.01% |
74,960
+11,741
| +19% | +$157K |
|
1629
BioCryst Pharmaceuticals
BCRX
$2.4B
| $941K | ﹤0.01% |
98,883
+12,363
| +14% | +$96K |
|
|
MPLT
1630
MapLight Therapeutics
MPLT
$552M
| $939K | ﹤0.01% |
+46,208
| New | +$827K |
|
1631
Beam Therapeutics
BEAM
$2.84B
| $925K | ﹤0.01% |
38,824
+1,922
| +5% | +$53.3K |
|
1632
Rogers Communications
RCI
$18.6B
| $924K | ﹤0.01% |
24,096
-45,123
| -65% | -$1.72M |
|
1633
Fulcrum Therapeutics
FULC
$297M
| $910K | ﹤0.01% |
118,600
-27,827
| -19% | -$258K |
|
1634
Vulcan Materials
VMC
$36.9B
| $909K | ﹤0.01% |
3,339
+1,843
| +123% | +$542K |
|
|
TECX
1635
Tectonic Therapeutic
TECX
$606M
| $904K | ﹤0.01% |
29,240
-8,139
| -22% | -$200K |
|
1636
Martin Marietta Materials
MLM
$33B
| $897K | ﹤0.01% |
1,524
+842
| +123% | +$537K |
|
1637
Dyne Therapeutics
DYN
$4.9B
| $886K | ﹤0.01% |
48,882
+1,786
| +4% | +$30.8K |
|
1638
Zebra Technologies
ZBRA
$17.8B
| $874K | ﹤0.01% |
4,179
+17
| +0.4% | +$3.99K |
|
1639
United Microelectronic
UMC
$46.9B
| $873K | ﹤0.01% |
+97,227
| New | +$948K |
|
1640
Pultegroup
PHM
$25.3B
| $873K | ﹤0.01% |
7,420
+2,648
| +55% | +$339K |
|
1641
Thomson Reuters
TRI
$44.1B
| $867K | ﹤0.01% |
9,491
-14,542
| -61% | -$1.53M |
|
1642
ADC Therapeutics
ADCT
$144M
| $866K | ﹤0.01% |
231,064
+18,149
| +9% | +$71.6K |
|
1643
Edgewise Therapeutics
EWTX
$4.73B
| $863K | ﹤0.01% |
27,409
-83,978
| -75% | -$2.42M |
|
1644
Baytex Energy
BTE
$2.92B
| $860K | ﹤0.01% |
+193,065
| New | +$712K |
|
1645
ADMA Biologics
ADMA
$2.22B
| $858K | ﹤0.01% |
95,213
-2,116
| -2% | -$33.4K |
|
1646
Aura Biosciences
AURA
$826M
| $853K | ﹤0.01% |
127,543
-13,416
| -10% | -$77K |
|
1647
Healthpeak Properties
DOC
$14.8B
| $841K | ﹤0.01% |
51,157
-5,387
| -10% | -$92.3K |
|
1648
PUT
iShares MSCI EAFE ETF
EFA
$80.2B
| $834K | ﹤0.01% |
10,875
+289
| +3% | +$28.9K |
|
1649
Immuneering
IMRX
$292M
| $824K | ﹤0.01% |
+156,424
| New | +$802K |
|
1650
PUT
American Express
AXP
$230B
| $824K | ﹤0.01% |
+2,536
| New | +$850K |
|
Similar funds
Wellington Management Group's Q1 2026 Portfolio in Review
As of Q1 2026, Wellington Management Group held 2,039 positions worth $535B, down 6.2% from $571B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Wellington Management Group's Q1 2026 filing shows 153 new, 707 increased, 906 reduced and 170 closed positions. Its largest new stake was Sunbelt Rentals Holdings: 11,221,373 shares worth $703M. The largest sale was Apple, an estimated $3.19B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Wellington Management Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 11,221,373 shares worth $703M.
- Wellington Management Group added most to AstraZeneca in Q1 2026, an estimated $2.38B increase.
- Wellington Management Group's biggest Q1 2026 reduction was Apple, cutting an estimated $3.19B.
- Wellington Management Group fully exited Synovus in Q1 2026, selling an estimated $341M.
- Wellington Management Group's ten largest holdings make up 26% of its $535B portfolio in Q1 2026.
- Wellington Management Group opened 153 new positions and closed 170 in Q1 2026.
- Wellington Management Group's portfolio value fell 6.2% quarter-over-quarter to $535B.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.